8-KThe WireRoutine
Reg FD Disclosure
Filed Feb 18, 2026 · 4mo ago · Accession 0001664710-26-000005
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Keros Therapeutics, Inc.
- Ticker
- KROS
- CIK
- 1664710
- Form type
- 8-K
- Filing date
- Feb 18, 2026
- Report date
- Feb 18, 2026
- Document
- kros-20260218.htm
- Size
- 210 KB